intracerebroventricular administration of dynorphin- ( 1-13 ) inhibits dose-dependently plasma vasopressin level in normal as well as in water-deprived rats , whereas systemic ( subcutaneous ) administration of this opioid peptide is ineffective in this respect .
C0013355
dynorphin
C0205753
opioid peptide